Evidence receipt / belief
Published · transcript-backedNoubar Afeyan: belief
13 Jan 2021 Conversations with Tyler Noubar Afeyan on the Permission to Leap
“I think if I just use that yardstick to go forward, that level of both increased knowledge about the pathophysiology, coupled with increased tools to address it with, I may be being too conservative, but I’d say over the next 5, 10 years, proof points — clear proof points — that that’s within reach should emerge.”
Source trail
Everything needed to verify it.
- Speaker
- Noubar Afeyan
- Attribution
- Verified speaker
- Claim type
- belief
- Recorded
- 13 Jan 2021
- Publisher
- Conversations with Tyler
Transcript context
…When do you think we will arrive at the point where dementia and Alzheimer’s — they may still be present, but they will not be significant social problems in the wealthiest countries? I’d like to see a more credible direction there over the next 5 to 10 years so that it will have impact in the 10- to 20-year time frame. If I just roll back the clock 20 years, much of what we’re doing today — cell therapies, messenger RNA, microbiome — none of those existed or were dreamt of, largely. I think if I just use that yardstick to go forward, that level of both increased knowledge about the pathophysiology, coupled with increased tools to address it with, I may be being too conservative, but I’d say over the next 5, 10 years, proof points — clear proof points — that that’s within reach should emerge. Here’s a very hard question again. What is the most important ethics question you face in your biosciences work? And how do you handle it or think about it?…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.